Scorpion Therapeutics

Drug Discovery

Scorpion Therapeutics is a private drug discovery company. It has raised $150 million across 3 recorded rounds; the latest was a $150 million Series C in Jul 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
Later Stage VC (Series C)
Jul 2024
Valuation — not yet established

No valuation for Scorpion Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($150.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Scorpion Therapeutics
  • ·15 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Scorpion Therapeutics funding history

3 rounds
DateRoundRaisedPost-money
Jul 2024Later Stage VC (Series C)$150.0M▮
Nov 2020Later Stage VC$147.0M▮
Apr 2020Early Stage VC$24.7M▮
Unlock post-money valuations

Membership and data by Private Market View

How much has Scorpion Therapeutics raised?

Scorpion Therapeutics has raised $150 million across 3 recorded rounds since 2020. The largest was a $24.7 million early-stage round in Apr 2020; the most recent was a $150 million Series C in Jul 2024.

Scorpion Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2024 ($126 million sold to 38 investors).

Institutional holders and vehicles

1 SEC-registered fund reported 15 fair-value marks on Scorpion Therapeutics between May 2025 and May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

How Scorpion Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Scorpion Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →

Frequently asked about Scorpion Therapeutics

How much has Scorpion Therapeutics raised?
Scorpion Therapeutics has raised $150.0M in total funding across 3 recorded rounds.
When did Scorpion Therapeutics last raise?
Scorpion Therapeutics last raised in Jul 2024 (Later Stage VC (Series C)), raising $150.0M.